Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care

por Karzai, Fatima, Dahut, William L.
Publicado 2022

Deciphering the enigma of neuroendocrine prostate cancer

por Karzai, Fatima, Madan, Ravi A.
Publicado 2022

Applications of large language models in cancer care: current evidence and future perspectives

por Iannantuono, Giovanni Maria, Bracken-Clarke, Dara, Floudas, Charalampos S., Roselli, Mario, Gulley, James L., Karzai, Fatima
Publicado 2023

Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine

por Madan, Ravi A., Redman, Jason M., Karzai, Fatima, Dahut, William L., Cordes, Lisa, Fakhrejahani, Farhad, Vu, Tuyen, Sheikh, Nadeem, Schlom, Jeffrey, Gulley, James L.
Publicado 2023

Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report

por Shell, Jasmine, Patel, Dhaval, Powers, Astin, Quezado, Martha, Killian, Keith, Meltzer, Paul, Zhu, Jack, Gaitanidis, Apostolos, Karzai, Fatima, Neychev, Vladimir, Green, Patience, Kebebew, Electron
Publicado 2017

First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report

por Atiq, Mohammad O., Pastor, Danielle M., Karzai, Fatima, Hankin, Amy R., Turkbey, Baris, Cordes, Lisa M., Brownell, Isaac, Liu, Yi, Chesnut, Gregory T., Madan, Ravi A.
Publicado 2023

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

por Bilusic, Marijo, Heery, Christopher R., Collins, Julie M., Donahue, Renee N., Palena, Claudia, Madan, Ravi A., Karzai, Fatima, Marté, Jennifer L., Strauss, Julius, Gatti-Mays, Margaret E., Schlom, Jeffrey, Gulley, James L.
Publicado 2019

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)

por Bilusic, Marijo, Toney, Nicole J., Donahue, Renee N., Wroblewski, Susan, Zibelman, Matthew, Ghatalia, Pooja, Ross, Eric A., Karzai, Fatima, Madan, Ravi A., Dahut, William L., Gulley, James L., Schlom, Jeffrey, Plimack, Elizabeth R., Geynisman, Daniel M.
Publicado 2022

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced...

por Gatti-Mays, Margaret E., Gameiro, Sofia R., Ozawa, Yohei, Knudson, Karin M., Hicks, Kristin C., Palena, Claudia, Cordes, Lisa M., Steinberg, Seth M., Francis, Deneise, Karzai, Fatima, Lipkowitz, Stanley, Donahue, Renee N., Jochems, Caroline, Schlom, Jeffrey, Gulley, James L.
Publicado 2021

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

por Bilusic, Marijo, McMahon, Sheri, Madan, Ravi A, Karzai, Fatima, Tsai, Yo-Ting, Donahue, Renee N, Palena, Claudia, Jochems, Caroline, Marté, Jennifer L, Floudas, Charalampos, Strauss, Julius, Redman, Jason, Abdul Sater, Houssein, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey, Gulley, James L
Publicado 2021

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

por Gatti‐Mays, Margaret E., Redman, Jason M., Donahue, Renee N., Palena, Claudia, Madan, Ravi A., Karzai, Fatima, Bilusic, Marijo, Sater, Houssein Abdul, Marté, Jennifer L., Cordes, Lisa M., McMahon, Sheri, Steinberg, Seth M., Orpia, Alanvin, Burmeister, Andrea, Schlom, Jeffrey, Gulley, James L., Strauss, Julius
Publicado 2019

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

por Hennigan, S. Thomas, Trostel, Shana Y., Terrigino, Nicholas T., Voznesensky, Olga S., Schaefer, Rachel J., Whitlock, Nichelle C., Wilkinson, Scott, Carrabba, Nicole V., Atway, Rayann, Shema, Steven, Lake, Ross, Sweet, Amalia R., Einstein, David J., Karzai, Fatima, Gulley, James L., Chang, Peter, Bubley, Glenn J., Balk, Steven P., Ye, Huihui, Sowalsky, Adam G.
Publicado 2019

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

por Abdul Sater, Houssein, Marté, Jennifer L, Donahue, Renee N, Walter-Rodriguez, Beatriz, Heery, Christopher R, Steinberg, Seth M, Cordes, Lisa M, Chun, Guinevere, Karzai, Fatima, Bilusic, Marijo, Harmon, Stephanie A, Turkbey, Ismail Baris, Choyke, Peter L, Schlom, Jeffrey, Dahut, William L, Madan, Ravi A, Pinto, Peter A, Gulley, James L
Publicado 2020

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

por DeMaria, Peter J, Lee-Wisdom, Katherine, Donahue, Renee N, Madan, Ravi A, Karzai, Fatima, Schwab, Angie, Palena, Claudia, Jochems, Caroline, Floudas, Charalampos, Strauss, Julius, Marté, Jennifer L, Redman, Jason Mark, Dombi, Eva, Widemann, Brigitte, Korchin, Borys, Adams, Tatiana, Pico-Navarro, Cesar, Heery, Christopher, Schlom, Jeffrey, Gulley, James L, Bilusic, Marijo
Publicado 2021

A case report of multiple primary prostate tumors with differential drug sensitivity

por Wilkinson, Scott, Harmon, Stephanie A., Terrigino, Nicholas T., Karzai, Fatima, Pinto, Peter A., Madan, Ravi A., VanderWeele, David J., Lake, Ross, Atway, Rayann, Bright, John R., Carrabba, Nicole V., Trostel, Shana Y., Lis, Rosina T., Chun, Guinevere, Gulley, James L., Merino, Maria J., Choyke, Peter L., Ye, Huihui, Dahut, William L., Turkbey, Baris, Sowalsky, Adam G.
Publicado 2020

Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer

por Madan, Ravi A, Karzai, Fatima, Donahue, Renee N, Al-Harthy, Munjid, Bilusic, Marijo, Rosner, Inger I, Singh, Harpreet, Arlen, Philip M, Theoret, Marc R, Marté, Jennifer L, Cordes, Lisa, Couvillon, Anna, Hankin, Amy, Williams, Moniquea, Owens, Helen, Lochrin, Sarah E, Chau, Cindy H, Steinberg, Seth, Figg, William Douglas, Dahut, William, Schlom, Jeffrey, Gulley, James L
Publicado 2021

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

por Strauss, Julius, Gatti-Mays, Margaret E, Cho, Byoung Chul, Hill, Andrew, Salas, Sébastien, McClay, Edward, Redman, Jason M, Sater, Houssein A, Donahue, Renee N, Jochems, Caroline, Lamping, Elizabeth, Burmeister, Andrea, Marté, Jennifer L, Cordes, Lisa M, Bilusic, Marijo, Karzai, Fatima, Ojalvo, Laureen S, Jehl, Genevieve, Rolfe, P Alexander, Hinrichs, Christian S, Madan, Ravi A, Schlom, Jeffrey, Gulley, James L
Publicado 2020

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

por Karzai, Fatima, VanderWeele, David, Madan, Ravi A., Owens, Helen, Cordes, Lisa M., Hankin, Amy, Couvillon, Anna, Nichols, Erin, Bilusic, Marijo, Beshiri, Michael L., Kelly, Kathleen, Krishnasamy, Venkatesh, Lee, Sunmin, Lee, Min-Jung, Yuno, Akira, Trepel, Jane B., Merino, Maria J., Dittamore, Ryan, Marté, Jennifer, Donahue, Renee N., Schlom, Jeffrey, Killian, Keith J., Meltzer, Paul S., Steinberg, Seth M., Gulley, James L., Lee, Jung-Min, Dahut, William L.
Publicado 2018

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

por Dinstag, Gal, Shulman, Eldad D., Elis, Efrat, Ben-Zvi, Doreen S., Tirosh, Omer, Maimon, Eden, Meilijson, Isaac, Elalouf, Emmanuel, Temkin, Boris, Vitkovsky, Philipp, Schiff, Eyal, Hoang, Danh-Tai, Sinha, Sanju, Nair, Nishanth Ulhas, Lee, Joo Sang, Schäffer, Alejandro A., Ronai, Ze’ev, Juric, Dejan, Apolo, Andrea B., Dahut, William L., Lipkowitz, Stanley, Berger, Raanan, Kurzrock, Razelle, Papanicolau-Sengos, Antonios, Karzai, Fatima, Gilbert, Mark R., Aldape, Kenneth, Rajagopal, Padma S., Beker, Tuvik, Ruppin, Eytan, Aharonov, Ranit
Publicado 2023

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

por Sowalsky, Adam G., Figueiredo, Ines, Lis, Rosina T., Coleman, Ilsa, Gurel, Bora, Bogdan, Denisa, Yuan, Wei, Russo, Joshua W., Bright, John R., Whitlock, Nichelle C., Trostel, Shana Y., Ku, Anson T., Patel, Radhika A., True, Lawrence D., Welti, Jonathan, Jimenez-Vacas, Juan M., Rodrigues, Daniel Nava, Riisnaes, Ruth, Neeb, Antje, Sprenger, Cynthia T., Swain, Amanda, Wilkinson, Scott, Karzai, Fatima, Dahut, William L., Balk, Steven P., Corey, Eva, Nelson, Peter S., Haffner, Michael C., Plymate, Stephen R., de Bono, Johann S., Sharp, Adam
Publicado 2022